CT for assessing ventricular remodeling

Is it ready for prime time?

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Reliable assessment of left ventricular size and systolic function has important prognostic and therapeutic implications for patients with heart disease. CT technology is advancing rapidly and can be used for noninvasive assessment of the coronary anatomy. Without additional radiation or contrast, the already acquired image data set can be used for analysis of left ventricular size, mass, and systolic function. In comparison with other noninvasive modalities, multidetector CT has superior spatial resolution but temporal resolution has suffered. Recent advances, including multisegment reconstruction and dual-source scanning, have improved the temporal resolution substantially. MRI is the current gold standard for assessing the left ventricle. Many small comparative studies suggest that CT has good agreement with MRI and that it could potentially replace MRI in some patients, especially those with internal cardiac devices. The use of CT to assess ventricular remodeling is limited by the use of contrast and radiation, but its widespread availability, ease of use, and improved temporal resolution suggest that multidetector CT will have expansive use in the future.

Original languageEnglish (US)
Pages (from-to)16-22
Number of pages7
JournalCurrent Heart Failure Reports
Volume5
Issue number1
DOIs
StatePublished - Dec 1 2008

Fingerprint

Ventricular Remodeling
Radiation
Heart Ventricles
Heart Diseases
Anatomy
Technology
Equipment and Supplies
Therapeutics

Cite this

CT for assessing ventricular remodeling : Is it ready for prime time? / Sigurdsson, Gardar.

In: Current Heart Failure Reports, Vol. 5, No. 1, 01.12.2008, p. 16-22.

Research output: Contribution to journalReview article

@article{bb19e0c43145415cac49514c0ed3c548,
title = "CT for assessing ventricular remodeling: Is it ready for prime time?",
abstract = "Reliable assessment of left ventricular size and systolic function has important prognostic and therapeutic implications for patients with heart disease. CT technology is advancing rapidly and can be used for noninvasive assessment of the coronary anatomy. Without additional radiation or contrast, the already acquired image data set can be used for analysis of left ventricular size, mass, and systolic function. In comparison with other noninvasive modalities, multidetector CT has superior spatial resolution but temporal resolution has suffered. Recent advances, including multisegment reconstruction and dual-source scanning, have improved the temporal resolution substantially. MRI is the current gold standard for assessing the left ventricle. Many small comparative studies suggest that CT has good agreement with MRI and that it could potentially replace MRI in some patients, especially those with internal cardiac devices. The use of CT to assess ventricular remodeling is limited by the use of contrast and radiation, but its widespread availability, ease of use, and improved temporal resolution suggest that multidetector CT will have expansive use in the future.",
author = "Gardar Sigurdsson",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/s11897-008-0004-2",
language = "English (US)",
volume = "5",
pages = "16--22",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - CT for assessing ventricular remodeling

T2 - Is it ready for prime time?

AU - Sigurdsson, Gardar

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Reliable assessment of left ventricular size and systolic function has important prognostic and therapeutic implications for patients with heart disease. CT technology is advancing rapidly and can be used for noninvasive assessment of the coronary anatomy. Without additional radiation or contrast, the already acquired image data set can be used for analysis of left ventricular size, mass, and systolic function. In comparison with other noninvasive modalities, multidetector CT has superior spatial resolution but temporal resolution has suffered. Recent advances, including multisegment reconstruction and dual-source scanning, have improved the temporal resolution substantially. MRI is the current gold standard for assessing the left ventricle. Many small comparative studies suggest that CT has good agreement with MRI and that it could potentially replace MRI in some patients, especially those with internal cardiac devices. The use of CT to assess ventricular remodeling is limited by the use of contrast and radiation, but its widespread availability, ease of use, and improved temporal resolution suggest that multidetector CT will have expansive use in the future.

AB - Reliable assessment of left ventricular size and systolic function has important prognostic and therapeutic implications for patients with heart disease. CT technology is advancing rapidly and can be used for noninvasive assessment of the coronary anatomy. Without additional radiation or contrast, the already acquired image data set can be used for analysis of left ventricular size, mass, and systolic function. In comparison with other noninvasive modalities, multidetector CT has superior spatial resolution but temporal resolution has suffered. Recent advances, including multisegment reconstruction and dual-source scanning, have improved the temporal resolution substantially. MRI is the current gold standard for assessing the left ventricle. Many small comparative studies suggest that CT has good agreement with MRI and that it could potentially replace MRI in some patients, especially those with internal cardiac devices. The use of CT to assess ventricular remodeling is limited by the use of contrast and radiation, but its widespread availability, ease of use, and improved temporal resolution suggest that multidetector CT will have expansive use in the future.

UR - http://www.scopus.com/inward/record.url?scp=47149114947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47149114947&partnerID=8YFLogxK

U2 - 10.1007/s11897-008-0004-2

DO - 10.1007/s11897-008-0004-2

M3 - Review article

VL - 5

SP - 16

EP - 22

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 1

ER -